HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

shexiang baoxin

used to treat carotid atherosclerosis

Networked: 64 relevant articles (8 outcomes, 12 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Complex Mixtures: 1906
- Biological Products
  - Plant Preparations: 622
    - Plant Extracts: 3916
      - Chinese Herbal Drugs: 73
        shexiang baoxin: 64
Pharmaceutical Preparations
- Chinese Herbal Drugs: 73
  - shexiang baoxin: 64

Experts

1.	Zhang, Weidong: 10 articles (07/2022 - 11/2011)
2.	Liu, Runhui: 6 articles (03/2015 - 11/2011)
3.	Jiang, Peng: 5 articles (01/2020 - 11/2011)
4.	Wang, Shuping: 5 articles (02/2015 - 11/2011)
5.	Lv, Chao: 4 articles (01/2017 - 02/2015)
6.	Xiang, Li: 4 articles (03/2014 - 11/2011)
7.	Zhan, Chang-Sen: 3 articles (01/2021 - 01/2019)
8.	Zhan, Changsen: 3 articles (01/2020 - 09/2012)
9.	Chen, Zhongliang: 3 articles (03/2014 - 11/2011)
10.	Liu, Xiaojun: 3 articles (03/2014 - 09/2012)

Related Diseases

1.	Myocardial Infarction 07/04/2023 - "Study of the mechanism of Shexiang Baoxin pill-mediated angiogenesis in acute myocardial infarction." 01/22/2021 - "This study will evaluate the efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction. " 01/22/2021 - "This is a prospective randomized controlled trial to study the efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction. " 01/22/2021 - "At present, there is a lack of strict randomized controlled trials to verify the efficacy and safety of Shexiang Baoxin Pill combined with Western medicine in the treatment of acute myocardial infarction. " 09/01/2023 - "Shexiang Baoxin Pill treats acute myocardial infarction by promoting angiogenesis via GDF15-TRPV4 signaling."
2.	Heart Failure 02/01/2023 - "To evaluate the therapeutic efficacy of Shexiang Baoxin Pill combined with exercise in heart failure patients with preserved ejection fraction (HFpEF). " 02/01/2023 - "Therapeutic Efficacy of Shexiang Baoxin Pill Combined with Exercise in Patients with Heart Failure with Preserved Ejection Fraction: A Single-Center, Double-Blind, Randomized Controlled Trial." 01/01/2018 - "Shexiang Baoxin Pills as an Adjuvant Treatment for Chronic Heart Failure: A System Review and Meta-Analysis." 01/01/2018 - "Shexiang Baoxin pills (SXBXP), as a Traditional Chinese Medicine, are widely used for chronic heart failure in China. " 12/01/2018 - "Therapeutic efficacy and safety of Shexiang Baoxin Pill combined with trimetazidine in elderly patients with heart failure secondary to ischaemic cardiomyopathy: A systematic review and meta-analysis."
3.	Cardiovascular Diseases (Cardiovascular Disease) 01/01/2022 - "Shexiang Baoxin Pill (SXBXP) is a widely used Chinese medicine for cardiovascular disease in China, and clinical studies have shown that it has good efficacy for CSF. " 01/01/2023 - "Aim: The Shexiang Baoxin Pill (SBP) has been extensively used to treat cardiovascular diseases in China for four decades, and its clinical efficacy has been widely approved. " 07/15/2022 - "Shexiang Baoxin Pill (SBP) and Suxiao Jiuxin Pill (SJP) are traditional Chinese medicines used to treat cardiovascular disease (CVD) in China. " 01/01/2021 - "Shexiang Baoxin Pill (SBP) is a proprietary Chinese medicine, initially used to treat cardiovascular diseases. " 01/01/2017 - "A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases."
4.	Angina Pectoris 09/01/2023 - "Shexiang Baoxin Pills + conventional western medicine had the best effect on reducing the incidence of adverse cardiovascular events, and Yixinshu Capsules + conventional western medicine on reducing the frequency and duration of angina pectoris. " 01/01/2021 - "206 patients with CHD angina pectoris in the hospital from July 2018 to May 2020 were selected as the research subjects and were enrolled into the control (Ctrl) group (conventional treatment, n = 103) and the observation group (the Shexiang Baoxin pill was given on the basis of conventional treatment, n = 103) in random. " 03/01/1998 - "To assess the effect of Shexiang Baoxin Pill (SXBXP) for labour angina pectoris. " 03/01/1998 - "[Assessment of effect of Shexiang Baoxin pill for labour angina pectoris patients with computerized tomography myocardial imaging]." 01/01/2021 - "Block Matching Pyramid Algorithm-Based Analysis on Efficacy of Shexiang Baoxin Pills Guided by Echocardiogram (ECG) on Patients with Angina Pectoris in Coronary Heart Disease."
5.	Coronary Disease (Coronary Heart Disease) 01/01/2017 - "Shexiang Baoxin Pills for Coronary Heart Disease in Animal Models: Preclinical Evidence and Promoting Angiogenesis Mechanism." 05/01/2010 - "[Evaluation on clinical effect of long-term shexiang baoxin pill administration for treatment of coronary heart disease]." 01/01/2021 - "Shexiang Baoxin Pill (SBP) is a licensed Chinese herbal pharmaceutical that has been widely accustomed to treat coronary heart disease (CHD) after percutaneous coronary intervention (PCI). " 01/01/2021 - "Efficacy and Safety of Shexiang Baoxin Pill for Coronary Heart Disease after Percutaneous Coronary Intervention: A Systematic Review and Meta-analysis." 03/01/2015 - "Shexiang Baoxin pills (SBP) are a traditional Chinese medicine that are used for treating coronary heart disease. "

Related Drugs and Biologics

1.	Therapeutic Uses
2.	Biomarkers (Surrogate Marker)
3.	Trimetazidine (Vastarel)
4.	Lipids
5.	Tablets
6.	Isoproterenol (Isoprenaline)
7.	Nonprescription Drugs (Patent Medicines)
8.	Yindan Xinnaotong
9.	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
10.	Ginsenosides

Related Therapies and Procedures

1.	Chinese Traditional Medicine (Traditional Chinese Medicine)
2.	Therapeutics
3.	Percutaneous Coronary Intervention
4.	Drug Therapy (Chemotherapy)